Evaluation of TB/HIV Collaborative Activities in Swaziland

The dual epidemic of HIV and AIDS and tuberculosis is one of the major health challenges faced by Swaziland. With a TB incidence rate of 733 TB cases per 100,000 per year and 73% of TB patients co-infected with HIV, Swaziland is listed among the 41 high TB/HIV burden countries. The country has made tremendous efforts to reduce the burden of TB among people living with HIV through the implementation of TB infection prevention and control measures, TB screening at all patient contact points, increasing access to TB diagnostic services including transportation of sputum samples through the national sample transportation network system, and early provision of anti-TB treatment among those diagnosed with TB. The country is also making efforts to decrease the burden of HIV among patients diagnosed with TB through implementing provider initiated HIV testing and counselling services, HIV infection preventive services and providing cotrimoxazole prophylaxis and ART to those who are HIV positive. The National TB/HIV Coordinating Committee serves as a platform for joint planning between the Swaziland National AIDS Programme (SNAP), National Tuberculosis Control Programme (NTCP) and collaborating partners and guides the implementation of integrated TB/HIV collaborative activities.

This report provides more evidence on strengths and weaknesses as we implement TB/HIV collaborative activities and acknowledges the good work that health care workers, implementing partners and programmes are doing in fighting HIV and TB in the country. The report identifies key performance areas that the HIV and TB Programmes need to improve in their collective quest to contain the dual epidemic, which has put enormous pressure on the health delivery system in Swaziland.

Report Author(s): 
Munyaradzi Pasipamire, Swaziland Natiational AIDS Programme; Ishani Pathmanathan, CDC, Division of Global HIV/AIDS, Atlanta; Marianne Calnan, University Research Co., LLC; Batsabile Simelane, University Research Co., LLC; Tony Ao Trong, Centres for Disease Control and Prevention, Swaziland; Samson Haumba, University Research Co., LLC
ASSIST publication: 
ASSIST publication
Facebook icon
Twitter icon
LinkedIn icon
e-mail icon